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Abstract
Prostatic acid phosphatase (PAP), the first diagnostic marker and present therapeutic target for prostate cancer, modulates
nociception at the dorsal root ganglia (DRG), but its function in the central nervous system has remained unknown. We
studied expression and function of TMPAP (the transmembrane isoform of PAP) in the brain by utilizing mice deficient in
TMPAP (PAP2/2mice). Here we report that TMPAP is expressed in a subpopulation of cerebral GABAergic neurons, and mice
deficient in TMPAP show multiple behavioral and neurochemical features linked to hyperdopaminergic dysregulation and
altered GABAergic transmission. In addition to increased anxiety, disturbed prepulse inhibition, increased synthesis of
striatal dopamine, and augmented response to amphetamine, PAP-deficient mice have enlarged lateral ventricles, reduced
diazepam-induced loss of righting reflex, and increased GABAergic tone in the hippocampus. TMPAP in the mouse brain is
localized presynaptically, and colocalized with SNARE-associated protein snapin, a protein involved in synaptic vesicle
docking and fusion, and PAP-deficient mice display altered subcellular distribution of snapin. We have previously shown
TMPAP to reside in prostatic exosomes and we propose that TMPAP is involved in the control of GABAergic tone in the
brain also through exocytosis, and that PAP deficiency produces a distinct neurological phenotype.
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Introduction
There are two isoforms of prostatic acid phosphatase enzyme:
secretory (sPAP) and transmembrane (TMPAP) [1,2] splice
variants encoded by the same gene (ACPP). TMPAP is a type 1
transmembrane protein with 59ectonucleotidase activity and is also
widely expressed in non-prostatic tissues in both sexes. TMPAP
contains an N-terminal phosphatase activity domain which is
extracellular when TMPAP is in the plasma membrane and intra-
luminal when it is trafficking in vesicles, and a C-terminal domain
with a cytosolic tyrosine-based endosomal-lysosomal (including
MVE) targeting signal motif (YxxW). TMPAP also colocalizes with
exosomal markers flotillin and Lamp-1 [1], is released in exosomes
and interacts in prostate cells with the SNARE-associated protein
snapin [3]. Snapin interacts biochemically with t-snare SNAP-25,
which belongs to the presynaptic release machinery [4], and is
critical for presynaptic homeostatic plasticity [5]. Additionally,
SNAP-25 is involved in slow clathrin-dependent endocytosis [6],
and alterations in clathrin-mediated endocytosis and clathrin-
dependent membrane and protein trafficking have been hypoth-
esized as core pathophysiological mechanisms in neuropsychiatric
disorders such as schizophrenia and bipolar disorders [7]. When
exosomes were described for the first time, it was shown that
exosomes display 59-ectonucleotidase activity [8].
In the DRG, TMPAP functions as a 59-ectonucleotidase and
produces adenosine [2,9] that suppresses pain by activating
adenosine A1-receptors. An intraspinal injection of sPAP has
efficient and long-lasting effects against pain sensation in healthy
animals, as well as pain reliving effects in animals sensitized by
nerve injury [9]. PAP2/2 mice have increased sensitivity for the
development of chronic inflammatory and neuropathic pain
[9,10]. Given the endosomal/lysosomal and exosomal localization
of TMPAP along with its known role in pain regulation in the
peripheral nervous system, this observation prompted us to
characterize PAP expression and function in the central nervous
system in more detail. We conclude that through an alteration in
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the mechanisms involving vesicular traffic, especially exocytosis,
the lack of PAP produces distinct endophenotypes, such as altered
prepulse inhibition, that are also seen in animal models of several
mental disorders.
Materials and Methods
Ethics Statement
All procedures and Experiments involving mice were approved
by ELLA - The National Animal Experiment Board of Finland.
The project license numbers are STH705A/ESLH-2009-08353/
Ym-23 and 044/11.
PAP Deficient Mice
PAP2/2 mice were generated by removing exon 3 (PAPD3/D3)
of the prostatic acid phosphatase gene (PAP, Acpp), completely
abolishing expression of sPAP and TMPAP proteins encoded by
the Acpp gene, respectively [10]. PAP2/2 mice have been
backcrossed to C57BL/6J strain (Harlan Laboratories, Inc.) for
16 generations. PAP2/2 male mice were analyzed with age-
matched C57BL/6J wild-type (WT) male mice as controls.
Magnetic Resonance Imaging
Mice 12-month-old (WT (n = 5) and PAP2/2 (n = 5)) and 2-
month-old (WT (n = 4) and PAP2/2 (n = 4)) were anesthetized
with isoflurane for the imaging experiment. MRI studies were
performed with a 4.7 T scanner (PharmaScan, Bruker BioSpin,
Ettlingen, Germany) using a 90-mm shielded gradient capable of
producing a maximum gradient amplitude of 300 mT/m with an
80-ms rise time. A linear birdcage radio frequency coil with an
inner diameter of 19 mm was used. After shimming and scout
images, coronal T2-weighted 2D images encompassing the whole
brain were acquired with using the standard Bruker technique of
fast spin echo sequence; rapid acquisition with relaxation
enhancement (RARE) sequence (TR/TEeff, 3800/80 millisec-
onds; Rare factor 8, matrix size, 2566256; field of view, 23623
mm2; 15 slices, slice thickness 0.5 mm). The body temperatures of
the animals were maintained by using a MRI-compatible heating
pad (Gaymar Industries,Orchard Park, NY, USA). Lateral
ventricle images were processed using the manual tracing tool
provided by ParaVision 4.0 (Bruker BioSpin, Ettlingen, Germany).
Manually delineated regions of interest for the right and the left
lateral ventricle in each slice were summed up and multiplied by
slice thickness yielding the right and left lateral ventricle volumes.
To calculate the total brain volume, the coronal sections obtained
by MRI were analyzed using ImageJ 1.48f program (Wayne
Rasband, National Institutes of Health, USA). Analysis of the MRI
images was performed so that the person analyzing the images did
not know the genotypes of the animals. The area corresponding to
the brain was selected using the free hand selection tool, and a
mask was generated (excluding cerebellum and olfactory bulbs).
Image calculation was performed for each slice of the image stack,
to the resulting images the automatic threshold adjustment was
applied, noise was removed and holes were filled. The area for
each image slice was calculated using the analyze particle tool.
Once all brain image slices were measured, the total brain volume
was calculated as the sum of every area multiplied by the slice
thickness. Groups were divided by genotype and age, and
Student’s t test was performed to compare brain size.
Behavioral Tests
Mice in behavioral tests. All mice (PAP2/2 and WT)
assayed in behavioral tests were 2.5 to 3.5-month-old.
Video tracking. The mice were video-tracked by Noldus
EthoVision XT 8.0 system (Noldus Information Technology,
Wageningen, The Netherlands) during the elevated plus-maze, Y-
maze, water maze, forced swim and tail suspension tests. The
distance travelled by the subjects and the time spent in pre-defined
zones were recorded.
Elevated plus maze. Elevated plus maze test (EPM) was
used to measure unconditioned anxiety-like behaviour in mice
(PAP2/2 n = 22, WT n = 23). The test was conducted as described
in [11]. Briefly, the maze consisted of two open arms (3065 cm)
and two enclosed arms (3065 cm, inner diameter) connected by
central platform (565 cm). The maze was raised to 40 cm above
the floor. The floor of each arm was light grey and the closed arms
had transparent (15 cm high) side- and end-walls. The illumina-
tion level in all arms was ,150 lx. The mouse was placed in the
center of the maze facing one of the enclosed arms and observed
for 5 minutes. The latency to the first open arm entry, number of
open and closed arm entries (four paw criterion) and the time
spent in different zones of the maze were measured.
Prepulse inhibition of acoustic startle
response. Sensorimotor gating (PPI) was measured in commer-
cially available system (Med Associates, St. Albans, GA, USA). For
initial screening 9 PAP2/2 and 9 WT mice were tested. The
method is described in details in [11]. Mice were enclosed in a
transparent plastic tube (Ø 4.5 cm, length 8 cm) that was placed in
the startle chamber (Med Associates) with a background white
noise of 65 dB and left undisturbed for 5 minutes. Testing was
performed in 12 blocks of 5 trials and five trial types were applied.
One trial type was a 40-ms, 120-dB white noise acoustic startle
stimulus (SS) presented alone. In the remaining four trial types the
startle stimulus was preceded by the acoustic prepulse stimulus
(PPS). The 20-ms PPS were white noise bursts of 68, 72, 76 and
80 dB. The delay between onset of PPS and SS was 100 ms. The
1st and 12th block consisted of SS-alone trials. In remaining blocks
the SS and PPS+SS trials were presented in pseudorandomized
order such that each trial type was presented once within a block
of 5 trials. The inter-trial interval ranged between 10 and 20
seconds. The startle response was recorded for 65 ms starting with
the onset of the startle stimulus. The maximum startle amplitude
recorded during the 65-ms sampling window was used as the
dependent variable. The startle response was averaged over 10
trials from blocks 2–11 for each trial type. The prepulse inhibition
for each PPS was calculated by using the following formula: 1002
[(startle response on PPS+SS trials/startle response on SS trials)
6100]. Finally, the average inhibition of the startle over all pre-
pulse levels was used for analysis. Haloperidol was dissolved in
saline and administered at the dose of 0.2 mg/kg i.p. 20 min
before start of experiment. Number of mice used: PAP2/2 n = 15
(saline) +15 (haloperidol), WT n = 15 (saline) +14 (haloperidol).
Amphetamine- and MK-801-induced locomotor
activity. The mice were adapted for 30 min in the open field
arena (30630 cm, Med Associates, St. Albans, VT, USA). After
adaptation, the animals received an i.p. injection of D-amphet-
amine (Faculty of Pharmacy, University of Helsinki, Finland;
3 mg/kg; PAP2/2 n = 15, WT n = 17) or MK-801 (Research
Biochemicals, Natick, MA, USA; 0.2 mg/kg; PAP2/2 n = 10, WT
Figure 1. Lateral ventricles volume is enlarged in PAP2/2 mice. Lateral ventricles (right and left ventricles) volume is significantly larger (**p,
0.01) in both young and old PAP2/2 mice compared to corresponding WT mice. (A) T2-weighted images from young (2 months) and old (12 months)
WT and PAP2/2 mice. Plot of (B) lateral ventricle volumes and (C) total brain size for WT and PAP2/2 mice. The data is expressed as mean6S.E.M.
doi:10.1371/journal.pone.0097851.g001
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n = 10) and the activity (distance travelled) was monitored for
90 min.
Diazepam-induced loss of righting reflex. The mice
(PAP2/2 n = 10, WT n = 10) were injected i.p. with high dose of
diazepam (Orion Pharma, Espoo, Finland; 35 mg/kg) and
checked for appearance of the loss of righting reflex by placing
on their backs in a v-shaped trough as described previously [12].
Light-dark exploration. The test was carried out in the
open field arena (30630 cm, Med Associates, St. Albans, VT)
equipped with infrared light sensors detecting horizontal and
vertical activity (PAP2/2 n = 22, WT n = 23). The dark insert
(non-transparent for visible light) was used to divide the arena into
two halves, an opening (a door with a width of 5.5 cm and height
of 7 cm) in the wall of the insert allowed animal’s free movement
from one compartment to another. The light half was illuminated
by two 40 W light bulb 50 cm above the floor (illumination in the
center of the light compartment ,1000 lx). Animal was placed in
the light compartment and allowed to explore the arena for 10
Figure 2. PAP2/2 mice show increased anxiety, disrupted PPI, augmented locomotor response to amphetamine and increased
tolerance to diazepam-induced loss of righting reflex. (A) PAP2/2mice spent less time in open arms of the elevated plus maze, and more time
in closed arms than WT mice. The ratio of open arm entries was lower in PAP2/2mice. (B) PAP2/2mice have reduced PPI of the acoustic startle reflex.
PPI was enhanced by treatment with haloperidol. (C) Amphetamine-induced locomotor activity was significantly increased in PAP2/2 mice compared
to WT mice (p = 0.0001), whereas the effect of MK-801 (D) was similar between the genotypes. (E) PAP2/2 mice displayed shorter duration of loss of
righting reflex after treatment with high dose of diazepam. The data is expressed as mean6S.E.M.; black bars/squares represent WT, grey bars/dots
PAP2/2 mice; *p,0.05 between the genotypes.
doi:10.1371/journal.pone.0097851.g002
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minutes. Distance travelled, number of rearings, and time spent in
different compartments were recorded.
Novelty-induced activity (Open Field). The mice were
released in the corner of novel open field arena (30630 cm, Med
Associates). Horizontal and vertical activity was recorded for one
hour (light intensity ,150 lx). Peripheral zone was defined as a
6 cm wide corridor along the wall (PAP2/2 n = 22, WT n = 23).
Y-maze. Spontaneous alternation performance was assessed
in a symmetrical Y-maze under reduced light conditions (,100 lx)
(PAP2/2 n = 10, WT n = 10). Each arm was 30 cm long and 7 cm
wide with transparent walls (15 cm high). Mice were allowed to
explore the maze for 5 minutes. The number and the sequence of
the arm entries were recorded. The measured variables were
activity, defined as the number of arms entered, and percent
alternation, calculated as the number of alternations (entries into
three different arms consecutively) divided by the total possible
alternations (i.e., the number of arms entered minus 2) and
multiplied by 100.
Rotarod. The accelerating rotarod (Ugo Basile, Comerio,
Italy) test was performed on two consecutive days (PAP2/2 n = 22,
WT n = 23). The mice were given three trials a day with an inter-
trial interval of 1 hour. Acceleration speed from 4 to 40 rpm over
a 5-min period was chosen. The latency to fall off was recorded
with the cut-off time set at 6 min.
Beam walking. The mouse is placed perpendicularly in the
center of a horizontal round beam (covered with laboratory tape,
outer diameter 2 cm, length 120 cm, divided into 12 sections and
raised to 50 cm above the floor level). If the mouse is falling off in
less than 10 sec, a new trial is started (max. 3 times). The retention
time and the number of sections crossed on the beam during
2 min are measured (PAP2/2 n = 22, WT n = 23).
Forced swim test. The mouse was placed for 6 minutes in
the glass cylinder (Ø 18 cm, height 25 cm) filled with water at
2361uC to the height of 15 cm. The time of immobility (passive
floating, when the animal was motionless or doing only slight
movements with tail or one hind limb, whereas the animal was
judged to be active when struggling, climbing or swimming using
all four paws) was measured in 2 min bins.
Tail suspension test. The mouse is fixed hanging by tail on
the horizontal bar with adhesive tape. The time of immobility (no
struggling) is measured during 6 min in 2 min bins (PAP2/2
n = 14, WT n = 12).
Fear conditioning. The experiments were carried out
employing a computer-controlled fear conditioning system (TSE)
(PAP2/2 n = 22, WT n = 23). Training was performed in a
transparent acrylic cage (23 6 23 6 35 cm) within a constantly
illuminated (, 100 lx) fear conditioning box. A loudspeaker
provided a constant, white background noise (68 dB) for 120 s
followed by 10 kHz tone (CS, 76 dB, pulsed 5 Hz) for 30 s. The
tone was terminated by a footshock (US, 0.6 mA, 2 s, constant
current) delivered through a stainless steel floor grid (Ø 4 mm,
distance 10 mm). Two CS-US pairings were separated by a 30 s
pause. Contextual memory was tested 24 h after the training. The
animals were returned to the conditioning box and total time of
freezing (defined as an absence of any movements for more than
3 s) was measured by infrared light barriers scanned continuously
with a frequency of 10 Hz. The CS was not used during this time.
Memory for the CS (tone) was tested 2 h later in a novel context.
The new context was a similarly sized acrylic box with black non-
Table 1. Anatomical, neurochemical and behavioral characterization of mice deficient in prostatic acid phosphatase (PAP).
Characteristic PAP2/2 mice
Enlarged lateral ventricles Yes
Dopamine q DA synthesis q DOPAC q DOPAC/DA
Gamma-aminobutyric acid (GABA) q frequency of GABAA-mediated mIPSC
Haloperidol response Yes
Diazepam-induced LORR Reduced
Sensorimotor gaiting (PPI) Reduced
Amphetamine hypersensitivity Increased
MK-801 hypersensitivity NSD
Anxiety-like behavior (EPM) Increased
Anxiety-like behavior (LD) NSD
Novelty-induced activity (OF) NSD
Short-term memory (Y-maze) NSD
Motor coordination (RR) NSD
Motor coordination (BW) NSD
Depression-like behavior (FST) NSD
Depression-like behavior (TST) NSD
Associative learning (FC) NSD
Social dominance (Tube-test) NSD
Social interaction (RI) NSD
Spatial learning and memory (WM) NSD
ABBREVIATIONS: NSD - no significant difference; q- increased; DA - dopamine; DOPAC - 3,4-Dihydroxyphenylacetic acid; GABAA - GABAA receptor; mIPSC -
miniature inhibitory postsynaptic current; LORR - loss of righting reflex; PPI - prepulse inhibition; EPM - elevated plus-maze; OF - open field; LD - light-dark box; RR - rota-
rod; BW - beam walking; FST - forced swim test; TST - tail suspension test; FC - fear conditioning; RI - resident-intruder test; WM - water maze.
doi:10.1371/journal.pone.0097851.t001
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transparent walls and smooth floor. A layer of wood chips under
the floor provided a novel odour to the chamber. After 120 s of
free exploration in a novel context the CS was applied for
additional 120 s and freezing was measured as above.
Tube test. Tube test is commonly used to measure social
dominance in mice (PAP2/2 n = 10, WT n = 10). Two unfamiliar
mice of the same sex but different genotypes were placed in the
opposite ends of a 3063.8 cm (inner diameter) transparent plastic
tube and released simultaneously. The match ended when one
mouse completely retreated from the tube. The mouse remaining
in tube is designated the winner, and the retreated mouse is the
loser. Each animal was tested against all animals from the opposed
group. The percent of retreated matches as well as aggressive
postures were scored for each animal. Matches lasting more than
2 min or in which animals crossed over each other were not
scored.
Resident-intruder test. Resident-intruder test was used to
measure social interaction (PAP2/2 n = 10, WT n = 10). An
intruder mouse (unfamiliar sex- and age-matched animal of
C57BL/6JOlaHsd strain) was put in the cage where the test mouse
had been acclimatizing for 30 min. Time spent in social activity
(sniffing, following, hetero-grooming) and non-social activity
(digging, self-grooming, and rearing) was recorded during 5 min
observation.
Water maze. The system consisted of a black circular
swimming pool (Ø 120 cm) and an escape platform (Ø 10 cm)
submerged 0.5 cm under the water surface in the centre of one of
four imaginary quadrants. The animals were released to swim in
random positions facing the wall and the time to reach the escape
platform (maximum time 60 s) and the swimming distance were
measured in every trial. In addition, thigmotaxis, the time spent
swimming within the outermost ring of the pool (10 cm from the
wall) was measured. Two training blocks consisting of three trials
each were conducted daily. The interval between trials was 4–
5 min and between training blocks about 5 hours. The hidden
platform remained in a constant location for 3 days (6 initial
training sessions) and was thereafter moved to the opposite
quadrant for 2 days (4 reverse training sessions). The probe trials
were conducted approximately 18 h after the last initial and
reverse training sessions. The mice were allowed to swim in the
maze for 60 seconds without the platform available. Spatial
memory in the probe trials was estimated by preference of
swimming in the trained region (imaginary circular area of Ø
30 cm, around the previous platform location) over swimming in
corresponding regions in the three other quadrants. After the 2nd
probe trial, the mice were tested for one block of 3 trials with the
platform made visible in the quadrant not employed previously
(PAP2/2 n = 4, WT n = 9).
Statistics
The behavioural data were analysed using a factorial ANOVA
design with genotype and treatment as between-subject factors. A
Figure 3. Dopamine synthesis is augmented in the striatum of PAP2/2 mice. (A) Tissue levels of DA are similar in WT and PAP2/2 mice. (B)
Level of the principal metabolite of DA, DOPAC, is elevated in the PAP2/2 mice, and also the DOPAC/DA ratio is elevated (C). (D) Accumulation of L-
DOPA is greater in PAP2/2 mice than WT mice 30 min after administration of a blocker of L-amino acid decarboxylase, indicating increased DA
synthesis. The data is expressed as mean6S.E.M.; black bars represent WT, grey bars PAP2/2 mice; *p,0.05, two tailed t-test (monoamines) or
repeated measures ANOVA (microdialysis).
doi:10.1371/journal.pone.0097851.g003
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repeated measures ANOVA was applied for analysis of activity
data. Post-hoc analysis after significant ANOVA was carried out
by means of Newman-Keuls test. Mann-Whitney U-test was used
for analysis of non-normally distributed data (diazepam-induced
LORR). For other experiments, data was analysed with either
two-tailed t-test or with repeated measures ANOVA.
Brain Dissection
The mice were sacrificed by decapitation and their brains
placed on an ice-cooled brain matrix (Stoelting, Wood Dale,
Illinois, USA). Two coronal cuts were made by razor blades at
about 1.5 and 20.3 mm from the bregma according to the mouse
brain atlas of Franklin and Paxinos [13]. From the obtained
section the dorsal striatum was punched below the corpus
callosum by using a sample corer (inner diameter of 2 mm).
Dissected tissue pieces were immediately placed into frozen
microcentrifuge tubes and after weighing they were stored at 2
80uC until assayed.
Figure 4. Characterization of dopaminergic transmission in PAP2/2 mice by microdialysis. (A) There is no difference in haloperidol
(0.2 mg/kg) -induced dopamine release between PAP2/2 and WT mice. (B) Adenosine A1-agonist GR79236X (1 mg/kg) and A1-antagonist 8-CPT
(300 mM in dialysis fluid) significantly decreased and increased the release of dopamine, respectively (repeated measures ANOVA) but there was no
difference in the magnitude of response between the genotypes. (C) There is no significant difference in potassium–induced DA release between the
genotypes, but amphetamine induces DA release significantly faster. The data is expressed as mean6S.E.M.; black squares represent WT, grey dots
PAP2/2 mice.
doi:10.1371/journal.pone.0097851.g004
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Estimation of Monoamines and their Metabolites
NSD-1015 (BioChemika, Sigma, China) was dissolved in saline
(0.9% NaCl solution) and given half an hour before the mice were
decapitated. Concentrations of dopamine (DA), L-dihydroxyphe-
nylacetic acid (DOPAC) and homovanillic acid (HVA) from brain
samples were analyzed using HPLC with electrochemical detec-
tion as described by [14]. The values of monoamines and their
metabolites are presented as nanograms per gram (ng/g) wet
weight of tissue.
In vivo Microdialysis
Guide cannulae (AgnTho’s, Lidingo¨, Sweden) were implanted
stereotaxically (coordinates A/P = +0.6, L/M = +1.8 and D/
V =22.3; [13] under isoflurane anesthesia [15]. After surgery,
mice were placed into individual test cages and allowed to recover
in the cages for at least 5 days before the experiment. On the
experiment day, a microdialysis probe (AgnTho’s, Lidingo¨,
Sweden, 1 mm membrane, outer diameter 0.24 mm, 6 kDa cut-
off, MAB 4.9.1 Cu) was inserted into the guide cannula, and the
probe was perfused with Ringer solution (147 mM NaCl, 1.2 mM
CaCl2, 2.7 mM KCl, 1.0 mM MgCl2, and 0.04 mM ascorbic
acid) at the flow rate of 2 ml/min. After a 3-h stabilization period,
Figure 5. TMPAP is expressed in the mouse brain and colocalizes with GABAergic marker, GAD 65/67. Representative confocal images
depict intense TMPAP (brown color) expression in molecular cell layer (M) and Purkinje cells (P) of cerebellum (Panel A), in substantia nigra pars
reticulata (SNpr; Panel B), in red nucleus (RN; Panel C) and in oculomotor nucleus (O; Panel C). Small picture in Panel B depicts the TMPAP staining of
the substantia nigra in PAP2/2mouse. TMPAP (green) was colocalized with GABAergic marker (red) in medium spiny neurons of striatum (Panels D-G,
yellow color and white arrows indicating the colocalization) and in SNpr (Panels H–K). Colocalization was evident also in GABAergic neurons of
hippocampus CA1 (Panels L–O). DAPI (blue color) was used as a nuclear marker. Scale bars are 500 mm in Panels A–C, and 10 mm in panels D–O.
doi:10.1371/journal.pone.0097851.g005
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Figure 6. The colocalization of PAP (green) and GAD65/67 (red) was seen in several areas of brain. In cerebral Purkinje cells (A–C), strong
colocalization was seen especially in the axon hillock of the neuron (small picture in C; yellow color and white arrows depicting the colocalization).
Similarly, PAP was present in GABAergic neurons in prefrontal cortex (PFC; infralimbic cortex) (D–F). Scale bars are 10 mm.
doi:10.1371/journal.pone.0097851.g006
Figure 7. The frequency of spontaneous hippocampal mIPSCs is increased in PAP2/2 mice. (A) Sample traces of mIPSC from WT and
PAP2/2 mice (P14–P18). (B) The mIPSC frequency in the PAP2/2 mice was higher (p=0.003) compared to WT mice. The graph shows the cumulative
distribution of the events. (C) Sample traces from 8 averaged mIPSCs from PAP2/2 and WT mice. (D) There were no differences in the amplitude in
mIPSCs recorded from WT and PAP2/2 mice. The graph shows the cumulative distribution of the amplitudes.
doi:10.1371/journal.pone.0097851.g007
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the collection of microdialysis samples was started. The concen-
trations of DA, DOPAC and HVA were determined by HPLC
with an electrochemical detector [15]. The column (Kinetex 2.6 m,
4.6650 mm C-18; Phenomenex, Torrance, CA, USA) was kept at
40uC, with a column heater (Croco-Cil; Bordeaux, France). The
mobile phase consisted of 0.1 M NaH2PO4 buffer, pH 4.0,
100 mg/ml octanesulphonic acid, 8% methanol and 1.0 mM
EDTA. The flow rate was 1.0 ml/min. Thirty five microliters of
the dialysate sample was injected into the column with a Shimadzu
SIL-20AC autoinjector (Shimadzu, Kyoto, Japan). Basal extracel-
lular concentrations of neurotransmitters (not corrected with
in vitro -recovery) were determined as mean of concentrations of
three stable pre-drug samples collected during the first 60 minutes
of sampling (variation ,20%). Potassium stimulation was
performed by manually switching the perfusion medium, Ringer,
to the one containing 100 mM KCl, 27.5 mM NaCl, 1.2 mM
CaCl2, 1.0 mM MgCl2, and 0.04 mM ascorbic acid. Haloperidol
(0.2 mg/kg i.p.), D-Amphetamine (100 mM; Faculty of Pharmacy,
University of Helsinki, Finland) and adenosine A1-antagonist 8-
CPT (300 mM; Research Biochemicals, Natick, MA, USA) were
given via dialysis fluid for 20 and 140 min., respectively.
Adenosine A1-agonist GR79236X (1 mg/kg) was given ip.
Sample Preparation for Immunohistochemistry
Mice were anesthetized using pentobarbital (100 mg/kg,
Mebunat Vet, Orion Pharma, Espoo, Finland) and perfused using
Figure 8. Immunofluorescent colocalization stainings of TMPAP and synaptic vesicle associated proteins. TMPAP (green) is colocalized
with a presynaptic marker, synaptophysin (red) (A–C; yellow color and white arrows depicting the colocalization). PAP was seen in vesicle-like
structures that had strong colocalization with Snapin (D–F). Small picture is a magnification from panel C, depicting the colocalization. Moreover,
largest PAP-immunoreactive structures had a colocalization with multivesicular bodies (MVB, red; G–I). All pictures are from striatum. Scale bars are
10 mm in A–C and G–I, and 3 mm in D–F.
doi:10.1371/journal.pone.0097851.g008
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phosphate buffered saline (PBS) followed by a perfusion with 4%
paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.4. After
perfusion, the mice were decapitated and brains were removed,
post-fixed with 4% paraformaldehyde and sucrose, and stored in
0.05% Na-azide in PBS at +4uC until sectioning into 40 mm free-
floating cryosections with a microtome (Leica SM2010, Leica
Microsystems Inc., Bannockburn, IL, USA).
PAP Immunohistochemistry (IHC)
PAP IHC for the mouse brain was performed by using free-
floating sections and modifying the protocol described in [16].
Shortly, the endogenous peroxidase activity was inactivated with
10% methanol and 3% H2O2 in PBS (pH 7.4) for 10 min, and
non-specific binding was blocked with 10% normal horse serum
(Product# S-2000, Vector laboratories, Burlingame, CA, USA) in
PBS. The sections were incubated overnight at room temperature
Figure 9. Immunostaining of Snapin in various brain areas of WT and PAP2/2 mice. In the PAP2/2 mouse, Snapin (red) is localized more
diffusely in the cell soma (B, D, F). Cellular localization of Snapin in WT mouse is more vesicular-like (A, C, E). Scale bar is 10 mm in all figures. M1 -
primary motor cortex; SN - substantia nigra.
doi:10.1371/journal.pone.0097851.g009
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with Goat anti-ACPP antibody (dilution 1:500 in 1% normal
serum; Product # EB09390, Everest Biotech, Oxfordshire, UK),
followed by washes with PBS. The slides were then incubated with
horse anti-goat biotin conjugated secondary antibody (dilution
1:500 in 1% normal serum; Product #BA9500, Vector laborato-
ries) for 2 h in room temperature, followed by PBS washes and
ABC incubation (Vectastain Elite ABC Kit, Product PK-6100,
Vector laboratories). The brown color was developed with 0.05%
3,39-diaminobenzidine and 0.03% H2O2 in PBS. Finally, the
sections were transferred to objective glasses, dehydrated in
alcohol series and mounted with Depex (BDH, Poole, UK).
PAP2/2 mouse served as a control for immunostainings.
Immunohistochemistry photomicrographs were captured by a
digital camera connected to the Olympus BX40 microscope and
DP50 Digital Camera (Olympus Corporation, Tokyo, Japan) and
corrections to brightness and contrast were made with Adobe
Photoshop CS2 software (version 9.0, Adobe Systems Incorporat-
ed, Mountain View, CA, USA).
Double-label Immunofluorescence
To detect the colocalization of PAP with GABAergic neurons,
double-label immunofluorescence was used as described in [17].
The sections were washed with PBS, non-specific binding was
blocked with 10% normal horse serum (Vector laboratories), and
the sections were incubated overnight in Goat anti-ACPP
antibody (dilution 1:500 in 1% normal serum; Everest Biotech,
Oxfordshire, UK). The slides were then incubated with donkey
anti-goat Alexa Fluor 488 conjugated secondary antibody (dilution
1:500 in 1% normal serum; Product #A11055, Invitrogen,
Eugene, OR, USA) for 2 h in room temperature, followed by
PBS washes. Then, the sections were incubated for 30 min in Goat
normal serum (Product #S1000, Vector laboratories) followed by
an overnight incubation with either rabbit anti-GAD 65/67
antibody (dilution 1:500 in 1% normal serum; Product #G5163,
Sigma-Aldrich), Rabbit anti-snapin (dilution 1:500 in 1% normal
serum, cat. no. 148 002, Synaptic Systems, Goettingen, Germany),
Rabbit anti-synaptophysin (dilution 1:500 in 1% normal serum,;
Product # ab14692 Abcam, Cambridge, UK), or rabbit anti-
CHMP2B (multivesicular bodies; dilution 1:500 in 1% normal
serum; Product #ab33174, Abcam, Cambridge, UK). After PBS
washes, the slides were incubated with goat anti-rabbit Texas Red
conjugated secondary antibody (dilution 1:500 in 1% normal
serum; Product #31506, Thermo Scientific, Rockford, IL, USA)
for 2 h in room temperature. The slides were then transferred to
objective glass, mounted with Vectashield with DAPI (Product
#H-1000, Vector laboratories) and coated with coverslip. The
sections were photographed using Leica TCS SP2 AOBS (Leica
Microsystems GmbH, Wetzlar, Germany) equipped with an
argon-He/Ne laser mounted on an inverted Leica DM IRE2
microscope (Leica Microsystems GmbH). Merging of images and
minor corrections to brightness and contrast were made with
Adobe Photoshop CS2 software (version 9.0, Adobe Systems
Incorporated, Mountain View, CA, USA).
Cloning of TMPAP from Striatal Neurons
Total RNA was isolated from Mouse Brain Striatum Neuronal
Cells (Lonza, Basel, Switzerland) using TriReagent (Molecular
Research Center, Cincinnati, OH, USA). RNA was reverse
transcribed into cDNA and subsequently amplified using Gen-
eAmp RNA PCR Kit (Life Technologies Ltd, Paisley, UK). The
primers used for TMPAP amplification by RT-PCR were: 59-
AATCTAGACCATGCCAGCCGTTCCT-39 (forward) and 59-
CTCTCTAGATCAGATTGTTCCGATACAC-39 (reverse).
The PCR conditions were: 95uC for 1 min and 45 s, followed
by 30 cycles of 95uC for 15 s, 63.4uC for 30 s, and 72uC for 1 min
and 12 s, with the final extension of 7 min at 72uC. PCR product
was cloned into pCR2.1 TOPO vector (Life Technologies Ltd.),
and bidirectionally sequenced.
Electrophysiology
Hippocampal slices (350 mm) were cut with a vibratome from
postnatal day (P) 14–18 WT or PAP2/2 mice (n = 14–16) using
standard methods [18]. The slices were used 1–4 h after cutting.
For electrophysiological recordings, the slices were placed in a
submerged chamber and superfused with artificial cerebrospinal
fluid (ACSF) containing: 124 mM NaCl, 3 mM KCl, 1.25 mM
NaH2PO4, 1 mM MgSO4, 26 mM NaHCO3, 15 mM d-glucose
and 2 mM CaCl2; 5% CO2–95% O2, at a rate of 2–3 ml/min
(32uC). Whole-cell recordings were obtained from CA1 pyramidal
neurons by using the Multiclamp 700B amplifier (Molecular
Devices, Sunnyvale, CA, USA). Cells were voltage-clamped at
0 mV with 4–5 MV pipettes filled with a solution containing:
135 mM CsMeSO4, 10 mM Hepes, 0.5 mM EGTA, 4 mM Mg-
ATP, 0.3 mM Na-GTP, 5 mM N-(2,6-dimethylphenylcarbamoyl-
methyl) triethylammonium chloride and 2 mM NaCl
(285 mOsm), pH 7.2. GABAA-mediated mIPSCs were recorded
in the presence of 1 mM TTX, 10 mM 2.3-dihydroxy-6-nitro-7-
sulfamoylbenzo(f)quinoxaline (NBQX), 1 mM 3-N[1-(S)-(3,4-di-
chlorophenyl)ethyl,] amino-2-(S)-hydroxypropyl-P-benzyl-phos-
phinic acid (CGP55845) and 50 mM D-2-amino-5-phosphonova-
lerate (D-AP5). All compounds were from Tocris (Bristol, UK).
Axoscope 10.2 (Molecular Devices) was used for data acquisition.
Offline analysis was done using MiniAnalysis 6.0.7 program
(Synaptosoft, GA, USA). Spontaneous events were detected using
peak detector algorithm, and all events were confirmed visually.
Rise and decay times were measured between 20 and 80% and
90–37% of the peak amplitude, respectively. The histograms and
cumulative distributions were constructed from at least 10 min of
recording (at least 50 events) from each cell, using a bin width of
100 ms for inter-event interval and 1 pA for amplitude. The
pooled data are given as mean 6 S.E.M. for the number of cells
indicated.
Results
To assess the function of TMPAP in the CNS, we first evaluated
the anatomy of the brain and performed MRI analyses of WT and
PAP2/2 mice. The results revealed that PAP2/2 mice had
significantly enlarged lateral brain ventricles (Fig. 1A and B) when
compared to WT. However, there was no significant difference in
brain size between genotypes (p.0.05, Fig. 1C), and the brain sizes
obtained were in agreement with published information [19].
Since PAP2/2 mice had significantly enlarged lateral brain
ventricles we subjected them at first to a detailed behavioral
analysis (Table 1). PAP2/2 mice displayed increased anxiety in the
elevated plus-maze test (Fig. 2A) and had a disruption in prepulse
inhibition (PPI), which indicates a defect in the sensorimotor
gating system. The administration of the typical antipsychotic drug
haloperidol improves the response of PAP2/2 mice in the PPI test
(Fig. 2B). In PPI of the startle reflex: initial screening showed
significantly reduced PPI in KO mice [F(1,16) = 9.7, p = 0.0067),
therefore we tested the effect of haloperidol (0.2 mg/kg) on PPI.
Factorial ANOVA with genotype (WT, KO) and treatment (saline,
haloperidol) as independent variables revealed significant main
effect of genotype [F(1,55) = 9.9, p = 0.0027] and treatment
[F(1,55) = 4.6, p = 0.0368]. There was no interaction between
the genotype and treatment. However, post-hoc Newman-Keuls
test revealed that treatment with haloperidol increased the PPI of
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KO mice to the level of WT mice treated with saline (p = 0.48) and
no difference was observed between KO and WT mice treated
with haloperidol (p = 0.09). Significant difference between saline
treated KO and WT mice was still evident (p = 0.05). PAP2/2
mice also showed an augmented response to the psychostimulant
D-amphetamine (Fig. 2C). However, the locomotor response of
PAP2/2 mice to MK-801, a NMDA receptor blocker and a
compound used to mimic psychosis in rodents, was normal
(Fig. 2D), suggesting that PAP2/2 mice have changes in their
dopaminergic system. PAP2/2 mice were also less sensitive to
diazepam-induced loss of righting reflex (Fig. 2E), indicating
alterations in GABAergic functions. PAP2/2 mice showed no
defects in tests measuring learning, memory, motor coordination,
social interaction or depression-like behavior (Table 1).
Due to the plausible changes in the dopaminergic system of
PAP2/2 mice, we measured the levels of dopamine (DA) and its
metabolites from the striatum of PAP2/2 mice by microanalysis,
and no notable difference were observed in the tissue concentra-
tion of DA (Fig. 3A). However, the level of its primary metabolite,
DOPAC, was increased 20% (Fig. 3B). The DOPAC/DA ratio
was also increased 30%, indicating increased synthesis or turnover
of DA (Fig. 3C). To discern which mechanism was causing the
increment in DOPAC, we studied DA synthesis rate by blocking
the dopadecarboxylase enzyme which converts L-dopa to DA by
using NSD1015 as inhibitor, and measured the accumulation of L-
dopa as an index of DA synthesis [20], and observed that the
accumulation of L-DOPA was 14% higher in PAP2/2 mice,
verifying augmented synthesis of DA (Fig. 3D).
To further characterize the dopaminergic transmission in
PAP2/2 mice we conducted a series of microdialysis experiments.
Given that DA D2-autoreceptors control the synthesis of
dopamine, we tested the difference in D2-receptor function in
PAP2/2 mice by administering haloperidol, but observed no
significant difference between the genotypes indicating normal D2-
receptor function in PAP2/2 mice (Fig. 4A). As we previously
showed that PAP produces adenosine that alleviates pain via A1
receptors [9], and A1 receptors modulate DA release [21],we also
tested striatal dopaminergic response to adenosine A1-receptor
agonist or antagonist in PAP2/2 mice by microdialysis, but saw no
difference between the genotypes, suggesting no difference in the
sensitivity of A1 receptors (Fig. 4B). Next, we tested whether there
is a difference between both genotypes in the capacity to release
DA by stimulating DA release with high concentration of
potassium or D-amphetamine in the dialysis fluid. We found that
D-amphetamine induces DA release significantly faster in the
PAP2/2 than in the WT mice (Fig. 4C).
These anatomical, neurochemical, and behavioral characteris-
tics observed in PAP2/2 mice suggested that PAP has an
important role in the central nervous system and prompted us to
characterize its localization and expression in the mouse brain.
Immunohistochemical stainings showed that TMPAP is widely
expressed in motor-related brain areas, with the most intense PAP-
immunoreactivity in cerebellar Purkinje cells, red nucleus,
oculomotor nucleus, and in substantia nigra pars reticulata
(Fig. 5A–C), and no PAP-immunoreactivity was seen in PAP2/2
sections (Fig. 5 B inset). We also cloned a full-length TMPAP
transcript from mouse striatal neurons (see Materials and
Methods), verifying expression of TMPAP. No sPAP transcript
was detected.
We queried the Allen Brain Atlas database [22] for expression
of PAP in mouse and human brain. In situ hybridization data of the
mouse brain was only available for sPAP (NM_019807), and
showed no expression of sPAP in the mouse brain, consistent with
our cloning findings. Gene expression data from the developing
human brain showed high levels of PAP expression (both sPAP
and TMPAP isoforms) in the ventricular and subventricular zones
[22].
Immunostaining revealed clear colocalization of TMPAP with
GABA-specific marker GAD65/67 in several brain areas (Fig. 5D–
O) (Fig. 6A–F), but hardly any TMPAP immunoreactivity outside
of GABAergic neurons. TMPAP was preferentially located in the
axon hillocks of GABAergic neurons (Fig. 6A–C) where GABAer-
gic synapses are located [23].
We next performed whole-cell patch-clamp recordings from
hippocampal CA1 pyramidal cells and observed increased
frequency of GABAA receptor-mediated mIPSCs in PAP2/2
mice (Fig. 7A–B). There was no change in the mIPSC amplitude
(Fig. 7C–D).
We have previously shown that TMPAP is localized presynap-
tically in the dorsal root ganglia and spinal cord [9]. Therefore, we
performed further colocalization studies of TMPAP with synapto-
physin, a marker of presynaptic nerve endings [24], and found
colocalization in large, vesicle-like structures (Fig. 8A–C), suggest-
ing that TMPAP is located at the presynaptic compartment also in
the brain. Since TMPAP colocalized with bis(monoacylglycero)-
phosphate, a marker for multivesicular bodies [1], and interacts
with snapin [3], we carried out double-immunostaining of
TMPAP and snapin, as well as TMPAP and anti-CHMP2B, also
a marker for multivesicular bodies. The immunofluorescence
stainings revealed colocalization of these proteins (Fig. 8D–I),
which suggests that cerebral TMPAP is also involved in endo2/
exocytosis. The lack of TMPAP in our PAP2/2 model also
produces a differential localization of snapin in the cells. In WT
animals snapin resides in vesicular structures, whereas in PAP2/2
mice snapin is localized more diffusely in the cell soma (Fig. 9).
Discussion
The anatomical, behavioral and neurochemical changes
observed in PAP2/2 mice (summarized in Table 1) suggest that
PAP has important supraspinal functions. The enlargement of
lateral ventricles has been observed in human neurodegenerative
diseases such as Alzheimer’s disease, dementia, bipolar disorder
and schizophrenia; and also in movement disorders like Parkin-
son’s and Huntington’s diseases [25–29]. A query of the Allen
Brain Atlas shows that in the adult human brain, PAP is highly
expressed in areas related to language, motor coordination,
cognitive function, and self-awareness; and PAP is also highly
expressed in the ventricular and subventricular zones of the
developing human brain [22]. We have not addressed the
expression of PAP in the developing mouse brain, but if like in
humans PAP is expressed during development in the ventricular
and subventricular zones, this could affect the development of the
brain and be an explanation for the enlarged lateral ventricles
observed in the PAP2/2 mice. It is important to mention that
previous studies have shown an increased incidence of spontane-
ous hydrocephaly in C57BL/6 mice compared to other mouse
strains [30]. Dahme and coworkers have shown that mutation in
the adhesion molecule L1 gene produces enlarged lateral ventricles
in mice with C57BL/6J background but this change was absent in
mice with 129/SvEv background [31]. Hence, the observed
phenotype of enlarged lateral ventricles in PAP2/2 mice might be
partially dependent on genetic background. However, enlarged
ventricles were only observed in PAP2/2 mice compared to WT
mice. Additionally, it has been shown that GABAergic neurons
regulate lateral ventricular development [32].
The phenotype of PAP2/2 mice is most likely not related to
adenosine, since there was no difference in striatal dopaminergic
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response to adenosine A1-receptor agonist or antagonist, suggest-
ing that other adenosine-synthesizing enzymes expressed in the
brain [33–35] most likely compensate for the lack of TMPAP. The
effect of amphetamine on locomotor activity of PAP2/2 mice was
augmented, which suggest altered dopaminergic response either in
the level of dopamine receptors or in the indirect mechanisms
controlling dopamine release. Indeed, microdialysis studies
showed that effect of amphetamine on striatal dopamine release
was more rapid in the PAP2/2 mice. Since the haloperidol-
induced dopamine release was not altered in the PAP2/2 mice,
their direct D2-receptor mediated control of DAergic transmission
seems to be normal. Thus, indirect mechanisms are more likely to
be involved. As amphetamine has a depressant effect on the firing
rate of DAergic neurons through the striatonigral neuronal
feedback loop [36], it is possible that the striatonigral GABAergic
feedback pathway controlling DA release is not functioning
normally, resulting in augmented response to amphetamine.
In addition, our results of whole-cell patch-clamp recordings
from hippocampal CA1 pyramidal cells show the increased
frequency of mIPSCs in PAP2/2 mice, suggesting either an
increase in the GABA release or in the density of GABAergic
synapses. The increase in GABAergic tone in PAP2/2 mice is also
in line with their decreased sensitivity to diazepam, as in the
presence of increased GABAergic tone the allosteric upmodulation
of GABAA receptors is likely to be less effective. On a cellular
level, how could TMPAP regulate GABAergic transmission to
produce such a distinct phenotype? TMPAP has an endosomal/
lysosomal targeting signal, and in prostate cancer tissue it is
localized in multivesicular endosomes and lysosomes, as well as
luminal exosomes [1,3]. In this study we have shown by
colocalization with CHMP2B that also in neurons TMPAP is in
multivesicular endosomes. In nerve cells, these organelles are used
in membrane trafficking pathways controlling recycling and
degradation of pre- and post-synaptic membrane proteins, as well
as in recycling of vesicle membrane during neurotransmitter
release [37] and release of exosomal endocargo [38].
The results of the colocalization studies with synapthophysin
and snapin, suggest that TMPAP is localized in synaptic nerve
endings. This conclusion is in agreement with previous studies
which show that mouse PAP localized presynaptically in DRG
neurons [9] and in taste buds [39]. In addition, the colocalization
between PAP and snapin in prostate cancer cells occurs in the cell
lamellipodia [3], and it has been described that the lamellipodium
is the site where exocytosis occurs in migrating mammalian cells
[40,41], supporting the hypothesis that colocalization of these
proteins in the neuron will not happen in the cell soma. This
presynaptic localization of TMPAP together with the fact that
TMPAP resides in the axon hillock, where GABAergic synapses
are located [23], supports the hypothesis that TMPAP is located in
GABAergic synapses. TMPAP also colocalizes and interacts with
snapin [3], which directly binds SNAP-25 [42], a protein that has
been linked to schizophrenia in genetic [43], pathological [44–46]
and functional studies [47–49]. Snapin is associated with the
SNARE complex and involved in synaptic vesicle docking and
fusion, supporting the hypothesis that TMPAP may regulate
GABAergic signaling via synaptic vesicle trafficking. The mis-
localization of snapin observed in the cells of PAP2/2 mice may
perturb synaptic processes controlling neurotransmitter release
and recycling, thus disrupting neuronal homeostasis and eventu-
ally leading to the neurological phenotype observed in PAP2/2
mice.
Enlarged lateral ventricles are present in numerous neurological
disorders such as schizophrenia, Alzheimer’s disease, bipolar
disorders, Parkinson’s disease and Huntington’s disease as well as
in many mouse models of the diseases [50–53]. Also, decreased
prepulse inhibition (PPI) is considered a behavioral endopheno-
type of schizophrenia [54]. To our knowledge, mutations in the
gene encoding PAP (ACPP) have not thus far been reported, nor
has ACPP been implicated in genetic association studies of mental
disorders. However, the SNAP-25 locus (Chr: 20p12.3-11) has
been implicated in a meta-analysis of genome-wide linkage scans
of schizophrenia [43]. GABAergic dysfunctions and alterations in
inhibitory circuits of the brain have been implicated in several
mouse models of schizophrenia and related disorders [55]). We
suggest that by influencing GABAergic signaling through vesicle
trafficking, TMPAP might be linked to specific endophenotypes
seen in neurological and neuropsychiatric disorders.
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